150 related articles for article (PubMed ID: 6233439)
1. Comparative effects of nicorandil and nitroglycerin on tracheal and vascular smooth muscle in the dog, in vivo and in vitro.
Nakamura Y; Shiraki Y; Nabata H; Sakai K
Jpn J Pharmacol; 1984 Mar; 34(3):269-76. PubMed ID: 6233439
[TBL] [Abstract][Full Text] [Related]
2. Comparative vasorelaxing profiles of nicorandil, isosorbide dinitrate and nitroglycerin in isolated coronary arteries of the dog.
Ohba Y; Shiraki Y; Sakai K
Jpn J Pharmacol; 1987 Nov; 45(3):397-404. PubMed ID: 2963927
[TBL] [Abstract][Full Text] [Related]
3. Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs.
Kuromaru O; Sakai K
Jpn J Pharmacol; 1986 Oct; 42(2):199-208. PubMed ID: 2948042
[TBL] [Abstract][Full Text] [Related]
4. KATP channel activation mediates nicorandil-induced relaxation of nitrate-tolerant coronary arteries.
O'Rourke ST
J Cardiovasc Pharmacol; 1996 Jun; 27(6):831-7. PubMed ID: 8761850
[TBL] [Abstract][Full Text] [Related]
5. Nitrate tolerance induced by nicorandil or nitroglycerin is associated with minimal loss of nicorandil vasodilator activity.
Henry PJ; Horowitz JD; Louis WJ
J Cardiovasc Pharmacol; 1990 Mar; 15(3):365-70. PubMed ID: 1691358
[TBL] [Abstract][Full Text] [Related]
6. Effects of nicorandil on the conductive coronary artery of the dog.
Imai S; Nakazawa M; Takeda K; Nakagawa Y; Katano Y; Tsukada T; Nabata H; Ushijima T
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S10-6. PubMed ID: 2447415
[TBL] [Abstract][Full Text] [Related]
7. Relaxing effect of nicorandil (N-2-(hydroxyethyl)-nicotinamide nitrate), a new anti-angina agent, on the isolated vascular smooth muscle.
Shibata S; Satake N; Takagi T; Kerfoot F; Suh TK
Eur J Pharmacol; 1984 Mar; 99(2-3):219-26. PubMed ID: 6234181
[TBL] [Abstract][Full Text] [Related]
8. Effects of nicorandil and its congeners on musculature and vasculature of the dog trachea in situ.
Maruyama M; Satoh K; Taira N
Arch Int Pharmacodyn Ther; 1982 Aug; 258(2):260-6. PubMed ID: 6215905
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in the vasorelaxing effect of nicorandil on dog epicardial coronary arteries: comparison with other NO donors.
Matsumoto T; Takahashi M; Omura T; Takaoka A; Liu Q; Nakae I; Kinoshita M
J Cardiovasc Pharmacol; 1997 Jun; 29(6):772-9. PubMed ID: 9234658
[TBL] [Abstract][Full Text] [Related]
10. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
Satoh K; Yamada H; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
[TBL] [Abstract][Full Text] [Related]
11. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
Borg C; Mondot S; Mestre M; Cavero I
J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478
[TBL] [Abstract][Full Text] [Related]
12. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory mechanisms of nicorandil in isolated rat urinary bladder and femoral artery.
Zhou Q; Satake N; Shibata S
Eur J Pharmacol; 1995 Jan; 273(1-2):153-9. PubMed ID: 7737309
[TBL] [Abstract][Full Text] [Related]
14. Nitrate tolerance: comparison of nicorandil, isosorbide dinitrate, and nitroglycerin in anesthetized dogs.
Sakai K; Kuromaru O
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S17-24. PubMed ID: 2447420
[TBL] [Abstract][Full Text] [Related]
15. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
[TBL] [Abstract][Full Text] [Related]
16. Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim.
Noguchi K; Matsuzaki T; Ojiri Y; Koyama T; Nakasone J; Sakanashi M
Fundam Clin Pharmacol; 1998; 12(3):270-8. PubMed ID: 9646059
[TBL] [Abstract][Full Text] [Related]
17. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
Greenberg SS; Cantor E; Ho E; Walega M
J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
[TBL] [Abstract][Full Text] [Related]
18. Dilator effects of nicorandil on isolated perfused coronary arteries of humans.
Sakaino N; Araki H; Nishi K
Arch Int Pharmacodyn Ther; 1990; 306():100-5. PubMed ID: 2150166
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic actions of nicorandil, a new antianginal agent, in the conscious dog.
Preuss KC; Gross GJ; Brooks HL; Warltier DC
J Cardiovasc Pharmacol; 1985; 7(4):709-14. PubMed ID: 2410712
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of the effects of nicorandil, pinacidil, nicardipine and nitroglycerin on coronary vessels in the conscious dog: role of the endothelium.
Ghaleh B; Dubois-Randé JL; Hittinger L; Giudicelli JF; Berdeaux A
Br J Pharmacol; 1995 Jan; 114(2):496-502. PubMed ID: 7881748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
